Affinia Therapeutics gets Health Canada approval to initiate UPBEAT phase 1/2 trial to investigate AFTX-201 to treat BAG3-associated DCM: Waltham, Massachusetts Tuesday, April 7, ...
All systems go at the House of Representatives for a high-level joint hearing on Wednesday, as 13 key committees convene in a ...
OpenAI unveiled a people-first AI policy blueprint Monday, warning small rule changes will not be enough as superintelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results